Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2026-02-28 @ 11:20 AM
Study NCT ID:
NCT02049450
Status:
COMPLETED
Last Update Posted:
2017-07-17
First Post:
2014-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-28
First Submit QC Date:
None
Study First Post Date:
2014-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-28
Results First Submit QC Date:
None
Results First Post Date:
2017-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-19
Last Update Post Date:
2017-07-17
Last Update Post Date Type:
ACTUAL